EcoDrugPlus

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSPNAG00000006485
Gene Symbol: LOC108439895
2 Cross references
214 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSPNAG00000003504
Gene Symbol: LOC108437450
2 Cross references
212 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3b

Ensembl ID : ENSPNAG00000020637
Gene Symbol: GRIA3B
1 Cross references
64 Possible Orthologues:

Glutaminase

Ensembl ID : ENSPNAG00000020958
Gene Symbol: GLS
3 Cross references
233 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSPNAG00000019393
Gene Symbol: LOC108410577
3 Cross references
228 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSPNAG00000010051
Gene Symbol: GSK3A
3 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSPNAG00000021421
Gene Symbol: GSK3B
3 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSPNAG00000000580
Gene Symbol: LOC108412552
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSPNAG00000003466
Gene Symbol: LOC108434709
3 Cross references
229 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSPNAG00000004797
Gene Symbol: GNRHR1
1 Cross references
135 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSPNAG00000000832
Gene Symbol: LOC108436550
2 Cross references
155 Possible Orthologues:

Granzyme B(G,h)-Like

Ensembl ID : ENSPNAG00000020007
Gene Symbol: LOC108429487
2 Cross references
993 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).